首页> 外国专利> Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5

Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5

机译:筛选由白细胞介素6、白细胞介素13、TNF、G-CSF、CXCL1、CXCL2或CXCL5引起的疾病的预防或治疗药物的方法,以及用于预防或治疗由白细胞介素6、白细胞介素13、TNF、G-CSF、CXCL1、CXCL2或CXCL5引起的疾病的药物的方法

摘要

Provided are a method for screening agents for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and an agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5. A method for screening agents for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 having as the index at least one selected from the group consisting of changes in the expression of the MEX3B gene or MEX3B protein and changes in the function of the MEX3B protein.
机译:本发明提供一种筛选用于预防或治疗由白细胞介素6、白细胞介素13、TNF、G-CSF、CXCL1、CXCL2或CXCL5引起的疾病的药物的方法,以及用于预防或治疗由白细胞介素6、白细胞介素13、TNF、G-CSF、CXCL1、CXCL2或CXCL5引起的疾病的药物。一种筛选用于预防或治疗由白细胞介素6、白细胞介素13、TNF、G-CSF、CXCL1、CXCL2或CXCL5引起的疾病的药物的方法,其具有从MEX3B基因或MEX3B蛋白的表达变化和MEX3B蛋白的功能变化组成的组中选择的至少一种作为指数。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号